HyperSight
Larger images. Better contrast. Faster CBCT imaging.
Welcome to HyperSight imaging: The next generation of in-room imaging.
HyperSight
6313898318112
Mire el video
simple-link
btn-submit
Hypersight
A Revolution in Resolution
Image Quality
Going beyond IGRT
- Improved image quality through enhanced contrast resolution, artifact suppression, and reduced non-uniformity.
- Designed to improve the ability to precisely target tumor volumes and increase sparing of healthy tissue during treatment.
- Metal artifact reduction algorithm improves image quality for patients with fiducials, hip prosthesis, and metal or dental implants.
- Larger Field Of View (FOV) allows clinicians to see anatomical changes more clearly which could trigger adaptation.
Precision
Images you can count on
- Delivers Hounsfield Unit (HU) accuracy rivaling that of conventional CT, enabling the calculation of the dose distribution directly on the CBCT image.
- The image reconstruction algorithms and the increased FOV delivers improved visualization of the patient volume and surrounding organs at risk (OARs)—enabling the generation of precise treatment plans.
- On Halcyon, CBCTp provides a new and unique guided workflow that enables you to generate CBCT images for initial treatment planning (CBCTp*) — including topogram, interactive isocenter placement, patient marking, and treatment position verification.
*CBCTp offered on Halcyon only
Central lung: 6 vs. 60 seconds
HyperSight on Halcyon
Images courtesy of Washington University, St Louis. Images acquired on Halcyon.
Speed
A single breath hold is all you need
- Images for all anatomical sites acquired with at least 50% increased gantry speed, aimed at:
- Reduced motion-related artifacts due to patient movement, and
- Reduced patient discomfort and anxiety due to less time on the couch
Patient outcomes improve when faster, clearer images guide our treatments. This technology not only potentially allows us to see the tumor better but to better target and tailor therapy to where it matters most.
Imaging Consortium
To compliment and facilitate a successful launch and beyond, we have created the Intelligent Imaging Consortium (IIC), a customer-led consortium chaired by Dr. James Robar, Chief of Medical Physics for Nova Scotia Health.
The IIC will give customers the space to adopt this new technology, co-collaborate and innovate on studies and trials together.
Put the power of the HyperSight imaging solution to work in your clinic today
Larger images. Better contrast. Faster CBCT imaging. With HyperSight, you can gain efficiencies, add new workflows, and expand the capabilities of your in-room imaging solution. Begin your transformation today—with the epic advancement in image quality, precision, and speed that is the HyperSight solution.
Resources
Product Overviews
- HyperSight Brochure
- HyperSight Bibliography
- HyperSight Overview 6313898318112 HyperSight Overview simple-linkHyperSight
Webinars
- TrueBeam With the HyperSight Imaging Solution: The Next Generation of In-Room Imaging
- Foundations of the HyperSight Imaging Solution
- TrueBeam with HyperSight Imaging Solution - The Ohio State Experience
- The Impact to Patients and Clinicians from Implementing the HyperSight Imaging Solution at a Community-based RT Center
- HyperSight Imaging Solution - Enhancing the Clinical Workflow and Patient Experience on Halcyon
Blogs
- The HyperSight Imaging Solution: A Revolution in Resolution for Single-Bunker Sites
- Varian Clinical Research Update: HyperSight Posters and Presentations at AAPM
- The HyperSight Revolution in Imaging Comes to TrueBeam
- Cutting-edge cancer imaging tool allows doctors to efficiently adapt radiotherapy treatment
We'll help you get connected
Our specialists can help you integrate Varian into your workflow.
If you are a current customer and need product support, please visit our Customer Support page.
modal
Request a presentation
btn-primary
Contact Form
basic-contact
marketo
1094
varian-paragraph-modal-marketo-form
HyperSight is an optional feature. Not available for sale in all markets.